Tuesday, July 21, 2026
🇺🇸 FDA

pharma · Diabetes Mellitus · Hemophilia A

Takeda

Takeda patent portfolio — 90 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Website Investor relations
Cambridge, USA HQ
1993 Founded
1,617 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Cambridge, USA
Founded
1993
Employees
1,617
Programs
19
Drugs
283
Patents
90
Official website ↗ All projects Drug pipeline Patents News & analysis

Recent coverage

View all news & analysis →
Intelligence · Patents

Takeda patents

90 pharmaceutical patents indexed for Takeda. 3 expire within 24 months.

Takeda has 90 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 3 expire within 24 months — use filters for patent-cliff planning.

All patents Expiring ≤12 months Expiring ≤24 months

90 patents

Patent portfolio

Page 2 of 2

  1. US 8758817

    Dosage form containing (S)-pantoprazole as active ingredient

    Expires Mon Jun 19 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 8754108

    Freeze-dried pantoprazole preparation and pantoprazole injection

    Expires Mon Jun 12 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 8703192

    Dosage form containing pantoprazole as active ingredient

    Expires Mon Apr 17 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 8697125

    Tablet preparation without causing a tableting trouble

    Expires Mon Apr 10 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 8663694

    Taste masked dosage form containing roflumilast

    Expires Mon Feb 27 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 8653107

    Fentanyl composition for nasal administration

    Expires Mon Feb 13 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 8648100

    Roflumilast for the treatment of pulmonary hypertension

    Expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 8642081

    Chewable, suckable and swallowable tablet containing a calcium-containing compound as an active substance

    Expires Mon Jan 30 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 8637079

    Solid preparation comprising alogliptin and pioglitazone

    Expires Mon Jan 23 2034 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 8618142

    Process for the preparation of roflumilast

    Expires Mon Dec 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 8604064

    Process for the preparation of roflumilast

    Expires Mon Dec 05 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 8541456

    Roflumilast for the treatment of diabetes mellitus type 2

    Expires Mon Sep 19 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 8536206

    Process for the preparation of roflumilast

    Expires Mon Sep 12 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 8519002

    Colchicine solid complex; methods of making; and methods of use thereof

    Expires Mon Aug 22 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 8486923

    Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

    Expires Mon Jul 11 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 8481516

    Ciclesonide containing sterile aqueous suspension

    Expires Mon Jul 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 8461187

    Multiple PPI dosage form

    Expires Mon Jun 06 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 8445541

    Methods for concomitant administration of colchicine and a second active agent

    Expires Mon May 16 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 8440722

    Methods for concomitant administration of colchicine and a second active agent

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 8440721

    Methods for concomitant administration of colchicine and a second active agent

    Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  21. US 8435497

    Formoterol of and ciclesonide combination

    Expires Mon May 02 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  22. US 8415396

    Colchine compositions and methods

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  23. US 8415395

    Colchicine compositions and methods

    Expires Mon Apr 04 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  24. US 8372872

    Methods for concomitant treatment of theophylline and febuxostat

    Expires Mon Feb 07 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  25. US 8173158

    Methods of treating gastrointestinal disorders independent of the intake of food

    Expires Mon May 03 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  26. US 8105626

    Granules containing acid-unstable chemical in large amount

    Expires Mon Jan 26 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  27. US 8071130

    Solid preparation

    Expires Mon Dec 01 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  28. US 8058280

    Substituted thieno[2,3-d]pyrimidin-2,4-dione compounds and uses thereof

    Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  29. US 7977488

    1-heterocyclylsulfonyl, 2-aminomethyl, 5-(hetero-) aryl substituted 1-H-pyrrole derivatives as acid secretion inhibitors

    Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  30. US 7807689

    Dipeptidyl peptidase inhibitors

    Expires Mon Sep 30 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  31. US 7790755

    Controlled release preparation

    Expires Mon Sep 02 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  32. US 7754220

    Methods of inhibiting secretion of follicle-stimulating hormone and testosterone

    Expires Mon Jul 08 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  33. US 7700128

    Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester

    Expires Mon Apr 15 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  34. US 7514441

    Substituted pyrazolo [1,5-A]pyrimidines as calcium receptor modulating agents

    Expires Mon Apr 02 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  35. US 7378108

    Percutaneous absorption preparation of compound having angiotensin II antagonistic activity

    Expires Mon May 22 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  36. US 7300935

    Thienopyrimidine compounds and use thereof

    Expires Mon Nov 22 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  37. US 7285668

    Process for the crystallization of (R)- or (S)-lansoprazole

    Expires Mon Oct 18 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  38. US 6420405

    Pharmaceutical composition for angiotensin II-mediated diseases

    Expires Mon Jul 11 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  39. US 6348481

    Pharmaceutical composition for angiotensin II-mediated diseases

    Expires Mon Feb 14 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  40. US 6228874

    Pharmaceutical composition for angiotensin II-mediated diseases

    Expires Mon May 03 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  41. US 6100252

    Heterocyclic compounds and their use as angiotensin antagonists

    Expires Mon Aug 03 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

  42. US 6025467

    Parathyroid hormone derivatives and their use

    Expires Mon Feb 10 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

    expired

Frequently asked questions

How many patents does Takeda have?

90 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Takeda patents expire?

3 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.